Deviation-based cost modeling: A novel model to evaluate the clinical and economic impact of clinical pathways

被引:91
作者
Vanounou, Tsafrir [1 ]
Pratt, Wande [1 ]
Fischer, Josef E. [1 ]
Vollmer, Charles M., Jr. [1 ]
Callery, Mark P. [1 ]
机构
[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gen Surg, Boston, MA 02215 USA
关键词
D O I
10.1016/j.jamcollsurg.2007.01.025
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: Although clinical pathways were developed to streamline patient care cost efficiently, few have been put to rigorous financial test. This is important today, because payors demand clear solutions to the cost-quality puzzle. We describe a novel, objective, and versatile model that can evaluate and link the clinical and economic impacts of clinical pathways. STUDY DESIGN: Outcomes for 209 consecutive patients undergoing high-acuity surgery (pancreaticoduodenectomy), before and after pathway implementation, were examined. Four grades of deviation (none to major) from the expected postoperative course were defined by merging length of stay with a validated classification scheme for complications. Deviation-based cost modeling (DBCM) links these deviations to actual total costs. RESULTS: Clinical outcomes compared favorably with benchmark standards for pancreaticoduodenectomy. Despite increasing patient acuity, this new pathway shortened length of stay, reduced resource use, and decreased hospital costs. DBCM indicated that fewer deviations from the expected course occurred after pathway implementation. The impacts of complications were less severe and translated to an overall cost savings of $5,542 per patient. DBCM also revealed that as more patients migrated to the expected course within our standardized care path, 50% of overall cost savings ($2,780) was attributable to the pathway alone, and improvements in care over time (secular trends) accounted for the remainder. CONCLUSIONS: DBCM accurately determined the incremental contribution of clinical pathway implementation to cost savings beyond that of secular trends alone. In addition, this versatile model can be customized to other systems' improvements to reveal their true clinical and economic impacts. This is valuable when choices linking quality with cost must be made. (J Am Coll Surg 2007; 204:570-579. (C) 2007 by the American College of Surgeons).
引用
收藏
页码:570 / 579
页数:10
相关论文
共 22 条
[1]  
[Anonymous], COST ENG
[2]   Partnering with payers to improve surgical quality: The Michigan plan [J].
Birkmeyer, NJO ;
Share, D ;
Campbell, DA ;
Prager, RL ;
Moscucci, M ;
Birkmeyer, JD .
SURGERY, 2005, 138 (05) :815-820
[3]  
Cameron JL, 2006, ANN SURG, V244, P10, DOI 10.1097/01.sla.0000217673.04165.ea
[4]  
Coffey R J, 1992, Qual Manag Health Care, V1, P45
[5]   Who pays for poor surgical quality? Building a business case for quality improvement [J].
Dimick, JB ;
Weeks, WB ;
Karia, RJ ;
Das, S ;
Campbell, DA .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2006, 202 (06) :933-937
[6]   Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey [J].
Dindo, D ;
Demartines, N ;
Clavien, PA .
ANNALS OF SURGERY, 2004, 240 (02) :205-213
[7]   Critical pathway effectiveness: Assessing the impact of patient, hospital care, and pathway characteristics using qualitative comparative analysis [J].
Dy, SM ;
Garg, P ;
Nyberg, D ;
Dawson, PB ;
Pronovost, PJ ;
Morlock, L ;
Rubin, H ;
Wu, AW .
HEALTH SERVICES RESEARCH, 2005, 40 (02) :499-516
[8]  
Falconer J A, 1993, QRB Qual Rev Bull, V19, P8
[9]   A prospective cost analysis of pancreatoduodenectomy [J].
Holbrook, RF ;
Hargrave, K ;
Traverso, LW .
AMERICAN JOURNAL OF SURGERY, 1996, 171 (05) :508-511
[10]   Impact of a clinical pathway for elective infrarenal aortic reconstructions [J].
Huber, TS ;
Carlton, LM ;
Harward, TRS ;
Russin, MM ;
Phillips, PT ;
Nalli, BJ ;
Flynn, TC ;
Seeger, JM .
ANNALS OF SURGERY, 1998, 227 (05) :691-701